The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | STDN Standard Nuclear, Inc. | Fundomo SN-001, LP owner | CConversion Series A Preferred Stockderivative | -3,849,782 | $0.00 | $0 | 0 | Jul 30, 2026 |
| Jul 17, 2026 | STDN Standard Nuclear, Inc. | Fundomo SN-001, LP owner | CConversion Series A-2 Preferred Stockderivativeindirect: By Fundomo SN-002, LP | -2,027,576 | $0.00 | $0 | 0 | Jul 30, 2026 |
| Jul 17, 2026 | STDN Standard Nuclear, Inc. | Fundomo SN-001, LP owner | CConversion Series Seed-1 Preferred Stockderivativeindirect: By ST-1014 Fund I, a series of Fundomo Syndicates, LP | -14,000,000 | $0.00 | $0 | 0 | Jul 30, 2026 |
| Jul 28, 2026 | CRWV CoreWeave, Inc. | Michael N Intrator CEO and President | CConversion Class A Common Stockindirect: Omnadora Capital LLC10b5-1 | +107,692 | - | - | 107,692 | Jul 30, 2026 |
| Jul 28, 2026 | CRWV CoreWeave, Inc. | Michael N Intrator CEO and President | CConversion Class B Common Stockderivativeindirect: Omnadora Capital LLC10b5-1 | -107,692 | - | - | 23,018,508 | Jul 30, 2026 |
| Jul 29, 2026 | GSHD Goosehead Insurance, Inc. | Mark Evan Jones Executive Chairman | CConversion Class B Common Stock | -125,000 | $0.00 | $0 | 6,870,180 | Jul 30, 2026 |
| Jul 29, 2026 | GSHD Goosehead Insurance, Inc. | Mark Evan Jones Executive Chairman | CConversion Class A Common Stock | +125,000 | $0.00 | $0 | 125,000 | Jul 30, 2026 |
| Jul 30, 2026 | GSHD Goosehead Insurance, Inc. | Mark Evan Jones Executive Chairman | CConversion Class B Common Stock | -2,519 | $0.00 | $0 | 6,867,661 | Jul 30, 2026 |
| Jul 30, 2026 | GSHD Goosehead Insurance, Inc. | Mark Evan Jones Executive Chairman | CConversion Class A Common Stock | +2,519 | $0.00 | $0 | 2,519 | Jul 30, 2026 |
| Jul 29, 2026 | GSHD Goosehead Insurance, Inc. | Mark Evan Jones Executive Chairman | CConversion LLC Units in Goosehead Financial, LLCderivative | -125,000 | $0.00 | $0 | 6,870,180 | Jul 30, 2026 |
| Jul 30, 2026 | GSHD Goosehead Insurance, Inc. | Mark Evan Jones Executive Chairman | CConversion LLC Units in Goosehead Financial, LLCderivative | -2,519 | $0.00 | $0 | 6,867,661 | Jul 30, 2026 |
| Jul 28, 2026 | GSHD Goosehead Insurance, Inc. | Chick & The Bear Irrevocable Trust owner, other | CConversion Class B Common Stock | -5,000 | $0.00 | $0 | 58,530 | Jul 30, 2026 |
| Jul 28, 2026 | GSHD Goosehead Insurance, Inc. | Chick & The Bear Irrevocable Trust owner, other | CConversion Class A Common Stock | +5,000 | $0.00 | $0 | 5,000 | Jul 30, 2026 |
| Jul 28, 2026 | GSHD Goosehead Insurance, Inc. | Chick & The Bear Irrevocable Trust owner, other | CConversion LLC Units in Goosehead Financial, LLCderivative | -5,000 | $0.00 | $0 | 58,530 | Jul 30, 2026 |
| Jul 28, 2026 | GSHD Goosehead Insurance, Inc. | Adrienne Kebodeaux owner, other | CConversion Class B Common Stock | -5,000 | $0.00 | $0 | 280,027 | Jul 30, 2026 |
| Jul 28, 2026 | GSHD Goosehead Insurance, Inc. | Adrienne Kebodeaux owner, other | CConversion Class A Common Stock | +5,000 | $0.00 | $0 | 5,000 | Jul 30, 2026 |
| Jul 28, 2026 | GSHD Goosehead Insurance, Inc. | Adrienne Kebodeaux owner, other | CConversion LLC Units in Goosehead Financial, LLCderivative | -5,000 | $0.00 | $0 | 280,027 | Jul 30, 2026 |
| Jul 29, 2026 | CDP CORPORATE OFFICE PROPERTIES TRUST | Robert L Denton director | CConversion Common Units-CDPLPderivative | -0 | $0.00 | $0 | 140,264 | Jul 30, 2026 |
| Jul 27, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class A Common Stockindirect: Canis Minor 2025 GRAT10b5-1 | +12,500 | - | - | 12,500 | Jul 29, 2026 |
| Jul 27, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class B Common Stockderivativeindirect: Canis Minor 2025 GRAT10b5-1 | -12,500 | - | - | 461,205 | Jul 29, 2026 |
| Jul 27, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class A Common Stock10b5-1 | +144,000 | - | - | 467,263 | Jul 29, 2026 |
| Jul 27, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class A Common Stockindirect: By Spouse10b5-1 | +25,000 | - | - | 25,000 | Jul 29, 2026 |
| Jul 27, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class A Common Stockindirect: Brannin J McBee 2022 Irrevocable Trust10b5-1 | +25,000 | - | - | 25,000 | Jul 29, 2026 |
| Jul 27, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class A Common Stockindirect: Canis Major 2024 Irrevocable Trust LLC10b5-1 | +3,000 | - | - | 3,000 | Jul 29, 2026 |
| Jul 27, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class A Common Stockindirect: Canis Major 2025 GRAT10b5-1 | +40,000 | - | - | 40,000 | Jul 29, 2026 |
| Jul 27, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class B Common Stockderivative10b5-1 | -144,000 | - | - | 5,898,894 | Jul 29, 2026 |
| Jul 27, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class B Common Stockderivativeindirect: By Spouse10b5-1 | -25,000 | - | - | 1,880,300 | Jul 29, 2026 |
| Jul 27, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class B Common Stockderivativeindirect: Brannin J. McBee 2022 Irrevocable Trust10b5-1 | -25,000 | - | - | 3,441,020 | Jul 29, 2026 |
| Jul 27, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class B Common Stockderivativeindirect: Canis Major 2024 Irrevocable Trust LLC10b5-1 | -3,000 | - | - | 300,000 | Jul 29, 2026 |
| Jul 27, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class B Common Stockderivativeindirect: Canis Major 2025 GRAT10b5-1 | -40,000 | - | - | 3,597,227 | Jul 29, 2026 |
| Jul 27, 2026 | SCTX Scribe Therapeutics, Inc. | Jennifer A Doudna owner | CConversion Common Stock | +12,511 | - | - | 603,547 | Jul 29, 2026 |
| Jul 27, 2026 | SCTX Scribe Therapeutics, Inc. | Jennifer A Doudna owner | CConversion Series A-1 Preferred Stockderivative | -74,088 | - | - | 0 | Jul 29, 2026 |
| Apr 16, 2026 | CITR CitroTech Inc. | Stephen Conboy owner, other | CConversion Common Stock, par value $0.0001 | +2,224 | - | - | 2,485,558 | Jul 29, 2026 |
| Apr 16, 2026 | CITR CitroTech Inc. | Stephen Conboy owner, other | CConversion Series C Convertible Preferred Stock, par value $0.0001derivative | -667 | - | - | 0 | Jul 29, 2026 |
| Jul 20, 2026 | FRNM Perceptive Capital Solutions Corp | Harlan Waksal other | CConversion Common Stock | +30,000 | - | - | 30,000 | Jul 29, 2026 |
| Jul 20, 2026 | FRNM Perceptive Capital Solutions Corp | Harlan Waksal other | CConversion Class B Ordinary Sharesderivative | -30,000 | - | - | 0 | Jul 29, 2026 |
| Jul 27, 2026 | SCTX Scribe Therapeutics, Inc. | AH Bio Fund II, L.P. owner | CConversion Common Stockindirect: By AH Bio Fund II, L.P. | +2,051,742 | - | - | 2,051,742 | Jul 29, 2026 |
| Jul 27, 2026 | SCTX Scribe Therapeutics, Inc. | AH Bio Fund II, L.P. owner | CConversion Common Stockindirect: By AH Bio Fund III, L.P. | +697,650 | - | - | 697,650 | Jul 29, 2026 |
| Jul 27, 2026 | SCTX Scribe Therapeutics, Inc. | AH Bio Fund II, L.P. owner | CConversion Series A Preferred Stockderivativeindirect: By AH Bio Fund II, L.P. | -12,150,003 | $0.00 | $0 | 0 | Jul 29, 2026 |
| Jul 27, 2026 | SCTX Scribe Therapeutics, Inc. | AH Bio Fund II, L.P. owner | CConversion Series B Preferred Stockderivativeindirect: By AH Bio Fund III, L.P. | -4,131,344 | $0.00 | $0 | 0 | Jul 29, 2026 |
| Jul 27, 2026 | SCTX Scribe Therapeutics, Inc. | Carl L Gordon director | CConversion Common Stockindirect: See footnotes | +348,825 | - | - | 348,825 | Jul 29, 2026 |
| Jul 27, 2026 | SCTX Scribe Therapeutics, Inc. | Carl L Gordon director | CConversion Series B Preferred Stockderivativeindirect: See footnotes | -2,065,672 | $0.00 | $0 | 0 | Jul 29, 2026 |
| Jul 27, 2026 | SCTX Scribe Therapeutics, Inc. | Orbimed Advisors LLC director | CConversion Common Stockindirect: See footnotes | +348,825 | - | - | 348,825 | Jul 29, 2026 |
| Jul 27, 2026 | SCTX Scribe Therapeutics, Inc. | Orbimed Advisors LLC director | CConversion Series B Preferred Stockderivativeindirect: See footnotes | -2,065,672 | $0.00 | $0 | 0 | Jul 29, 2026 |
| Jul 24, 2026 | GIPR GENERATION INCOME PROPERTIES, INC. | David Sobelman Chairman, President, CEO | CConversion Common Stock | +162,163 | $0.00 | $0 | 185,563 | Jul 29, 2026 |
| Jul 24, 2026 | HOOD Robinhood Markets, Inc. | Baiju Bhatt Chief Creative Officer | CConversion Class A Common Stockindirect: By Living Trust10b5-1 | +49,223 | - | - | 49,223 | Jul 28, 2026 |
| Jul 24, 2026 | HOOD Robinhood Markets, Inc. | Baiju Bhatt Chief Creative Officer | CConversion Class B Common Stockderivativeindirect: By Living Trust10b5-1 | -49,223 | $0.00 | $0 | 46,899,256 | Jul 28, 2026 |
| Jul 25, 2026 | GOOGL Alphabet Inc. | Marsida Saraci VP, Chief Accounting Officer | CConversion Class C Google Stock Units | -121 | $0.00 | $0 | 1,825 | Jul 28, 2026 |
| Jul 25, 2026 | GOOGL Alphabet Inc. | Marsida Saraci VP, Chief Accounting Officer | CConversion Class C Google Stock Units | -101 | $0.00 | $0 | 3,950 | Jul 28, 2026 |
| Jul 25, 2026 | GOOGL Alphabet Inc. | Marsida Saraci VP, Chief Accounting Officer | CConversion Class C Google Stock Units | -69 | $0.00 | $0 | 4,354 | Jul 28, 2026 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.